A Maturity Level Model (MLM) for the self-assessment of genomic medicine practices in healthcare systems
Creators
- Cardoso, maria Luis1
- Lopes, Fatima1
- Costa, Alexandra1
- Santos, Osvaldo2
- Konopko, Melissa3
- Merchant, Arshiya3
- Thorogood, Adrian4
- Saunders, Gary5
- Custers, Ilse6
- Bulcke, Marc Van Den7
- Schmitt, Tugce7
- Bogicevic, Ivana8
- Cividanes, Lene8
- Spalding, Dylan9
- Smith, Maeve10
- Bale, Mark10
- Pitini, Erica11
- Villari, Paolo12
- Baccolini, Valentina12
- Balciuniene, Anzelika13
- Ambrozaityte, Laima14
- Doménech, Elena15
- Martin-Sanchez, Fernando15
- Sobrón, Francisco16
- Saiz, Maria Luisa16
- Carracedo, Angel17
- Wedell, Anna18
- Thomsen, Anne Cambon19
- Veimer, Annika20
- Lundgren, Bettina8
- Solary, Eric21
- Birney, Ewan22
- Martins, Henrique23
- Klovins, Janis24
- Saarela, Janna25
- North, Kathryn26
- Caulfield, Mark27
- Piha, Tapani28
- Scollen, Serena3
- Vicente, Astrid1
- 1. Instituto Nacional de Saúde Doutor Ricardo Jorge
- 2. Lab, Instituto de Saúde Ambiental da Faculdade de Medicina da Universidade de Lisboa
- 3. ELIXIR
- 4. Terry Fox Research Institute
- 5. EATRIS
- 6. Lygature
- 7. Sciensano
- 8. Danish National Genome Center
- 9. CSC - IT Centre for Science
- 10. Dr Steevens Hospital, Dublin
- 11. Ministry of Health, Rome, Italy
- 12. Sapienza University of Rome, Rome, Italy
- 13. Ministry of Health, Vilnius, Lithuania
- 14. Vilnius University Hospital Santaros Klinikos Vilnius, Lithuania
- 15. Instituto de Salud Carlos III
- 16. Ministry of Health, Madrid, Spain
- 17. University of Santiago de Compostela
- 18. Centre for Inherited Metabolic Diseases, Karolinska University Hospital
- 19. CERPOP
- 20. Tervise Arengu Instituut Tallinn, Estonia
- 21. Institut de Cancérologie Gustave Roussy Villejuif, France
- 22. EMBL-EBI
- 23. ISCTE Instituto Universitário de Lisboa Unidade de Investigação em Desenvolvimento Empresarial
- 24. 30 Latvian Biomedical Research and Study Centre
- 25. Centre for Molecular Medicine Norway, University of Oslo
- 26. Murdoch Children's Research Institute, Melbourne, Australia
- 27. Queen Mary University of London
- 28. Pihanet Consulting, Helsinki, Finland
Description
Genomic medicine implementation in healthcare systems can bring us one step closer to making personalised medicine a reality, with major socioeconomic benefits. Citizens and patients can widely benefit from genomic data analysis for accurate and timely diagnosis, effective treatments with less adverse events, and accurate profiling for disease prevention. Implementation of genomics in healthcare is complex and requires adjustments in the governance, structure and organization of health services, as well as dedicated investments. Implementation is also dependent on the country context.
In the context of the 1+Million Genomes (1+MG) initiative, we developed a Maturity Level Model (MLM) for health systems to self-evaluate the maturity of their genomic medicine practices, and define a path to optimization. MLM is a tool for healthcare systems to self-evaluate the level of maturity of their genomic medicine practices according to a common matrix, and to define a path to optimization.
A MLM pilot in eight European countries provided important information regarding common strengths, weaknesses and asymmetries across Europe.
Files
ESHG 23_Poster MLM_Final.pdf
Files
(901.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:cfdd16dd714d71d28094160fbcfcdb7c
|
901.3 kB | Preview Download |